Randomised double blind placebo controlled trial of inhaled fluticasone propionate in infants with chronic lung disease.
In a double blind randomised controlled trial, 30 infants with chronic lung disease received fluticasone propionate or placebo for one year. There were no significant differences between treatment groups in the incidence of any day or night time symptoms or any other outcome measures.
Beresford
M W
MW
Royal Liverpool Children's NHS Trust, Alder Hey, UK Sheffield Children's Hospital NHS Trust, UK.
Primhak
R
R
Subhedar
N V
NV
Shaw
N J
NJ
D000280:Administration, Inhalation; D000287:Administration, Topical; D000730:Androstadienes / Q000008:administration & dosage*; D000893:Anti-Inflammatory Agents / Q000008:administration & dosage*; D001993:Bronchodilator Agents / Q000008:administration & dosage*; D004311:Double-Blind Method; D005260:Female; D000068298:Fluticasone; D005865:Gestational Age; D005938:Glucocorticoids; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007234:Infant, Premature; D007235:Infant, Premature, Diseases / Q000188:drug therapy*; D008171:Lung Diseases / Q000188:drug therapy*; D008297:Male; D010100:Oxygen / Q000008:administration & dosage; D012120:Respiration Disorders / Q000209:etiology / Q000517:prevention & control
D000730:Androstadienes; D000893:Anti-Inflammatory Agents; D001993:Bronchodilator Agents; D005938:Glucocorticoids; D000068298:Fluticasone; D010100:Oxygen